NYSE / NASDAQ · SEC EDGAR

Equity research

Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.

Research preview · Quarterly financial statements · No price quotes · Not financial advice

2–3 year stock research →

7626Listed tickers in the SEC universe 4350Issuers with current reporting periods 1430Issuers with both EPS and ROE metrics 2026-11-06Fundamentals evaluated as of

Example screens

Period 1M3M6M1Y5YMAX
Drawing LineCandles
Reset filters

All selected filters are combined. Paste up to 100 tickers to intersect your own list with the results. A missing metric does not pass a numeric filter.

1376 companies match

Showing 1051–1100 of 1376 · page 22/28

Per page 2550100

Companies with a published price series: 1374 of 1376 · Daily EOD closes from the BibaMoney price store (splits reflected, cash dividends not) · 2026-11-06

NTAP NASDAQ

NetApp, Inc.

199.18 +456.06% MAX
Combined rank
—
EPS acceleration
—
ROE
94.8%
NTNX NASDAQ

Nutanix, Inc.

67.21 +81.65% MAX
Combined rank
—
EPS acceleration
—
ROE
214.5%
NTRA NASDAQ

Natera, Inc.

414.30 +3629.07% MAX
Combined rank
—
EPS acceleration
—
ROE
-10.6%
NTSK NASDAQ

Netskope Inc

24.30 +6.91% MAX
Combined rank
—
EPS acceleration
—
ROE
-470.2%
NUWE NASDAQ

Nuwellis, Inc.

5.68 -100.00% MAX
Combined rank
—
EPS acceleration
—
ROE
—
NVCR NASDAQ

NovoCure Ltd

13.15 +53.98% MAX
Combined rank
—
EPS acceleration
—
ROE
-34.7%
NXGL NASDAQ

NEXGEL, INC.

3.51 -93.28% MAX
Combined rank
—
EPS acceleration
—
ROE
-125.0%
NXXT NASDAQ

NEXTNRG, INC.

2.75 -99.97% MAX
Combined rank
—
EPS acceleration
—
ROE
—
OABI NASDAQ

OmniAb, Inc.

5.11 -47.64% MAX
Combined rank
—
EPS acceleration
—
ROE
-17.4%
OCGN NASDAQ

Ocugen, Inc.

0.70 -99.64% MAX
Combined rank
—
EPS acceleration
—
ROE
—
ONDS NASDAQ

Ondas Inc.

6.32 -32.26% MAX
Combined rank
—
EPS acceleration
—
ROE
10.6%
ORCL NYSE

ORACLE CORP

123.73 +201.49% MAX
Combined rank
—
EPS acceleration
—
ROE
28.3%
OUST NASDAQ

Ouster, Inc.

29.74 -69.02% MAX
Combined rank
—
EPS acceleration
—
ROE
-8.2%
OWLT NYSE

Owlet, Inc.

4.05 -97.03% MAX
Combined rank
—
EPS acceleration
—
ROE
-38.1%
P NYSE

Everpure, Inc.

126.98 +837.12% MAX
Combined rank
—
EPS acceleration
—
ROE
16.4%
PATH NYSE

UiPath, Inc.

13.73 -80.93% MAX
Combined rank
—
EPS acceleration
—
ROE
18.6%
PAVM NASDAQ

PAVmed Inc.

1.95 -99.97% MAX
Combined rank
—
EPS acceleration
—
ROE
-34.5%
PBF NYSE

PBF Energy Inc.

78.00 +244.52% MAX
Combined rank
—
EPS acceleration
—
ROE
34.1%
PDEX NASDAQ

PRO DEX INC

58.16 +1169.87% MAX
Combined rank
—
EPS acceleration
—
ROE
24.4%

How the lists overlap

EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.

The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.

Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.

What this data covers

Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.

The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.

Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.

Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-11-05. Source: FRED / Federal Reserve.